Evaluation of 1-Year Clinical Outcomes With Early Inclisiran Initiation in Post-MI Patients
Conditions
Myocardial Infarction
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Novartis Investigative Site, Cheboksary, Russia
Novartis Investigative Site, Grozny, Russia
Novartis Investigative Site, Kemerovo, Russia
Novartis Investigative Site, Khanty-Mansiysk, Russia
Novartis Investigative Site, Moscow, Russia
Novartis Investigative Site, Moscow, Russia
Novartis Investigative Site, Moscow, Russia
Novartis Investigative Site, Novosibirsk, Russia
Novartis Investigative Site, Penza, Russia
Novartis Investigative Site, Petrozavodsk, Russia
Novartis Investigative Site, Rostov-on-Don, Russia
Novartis Investigative Site, S Petersburg, Russia
Novartis Investigative Site, Samara, Russia
Novartis Investigative Site, Syktyvkar, Russia
Novartis Investigative Site, Tomsk, Russia
Novartis Investigative Site, Ulan-Ude, Russia
Study leads
Novartis Pharmaceuticals
Study Director
Novartis Pharmaceuticals